Home / Market News / $HCA
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

RBC Raises Price Target on HCA Healthcare to $521

Oct 30, 2026, 12:04 PM UTC · Primary ticker $HCA

RBC Capital Markets has increased its price target for HCA Healthcare to $521 from $496, while reiterating an Outperform rating. This adjustment follows the company's Q3 2026 earnings report, suggesting a positive re-evaluation of HCA's financial outlook by the firm.

RBC Capital Markets has raised its price target on HCA Healthcare to $521, up from $496, and maintained its Outperform rating. This move comes after HCA's Q3 2026 earnings report, indicating that RBC analysts likely found the results favorable or saw improved future prospects for the company. For traders, this signals a positive sentiment from a major investment bank, potentially leading to increased investor confidence and short-term upward price momentum for HCA. The long-term implications depend on whether HCA can continue to meet or exceed expectations, justifying the higher valuation. A key opportunity for traders is to capitalize on any immediate positive reaction in HCA's stock price.

$HCA positive Price target increase and Outperform rating maintained
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.